Alnylam Pharmaceuticals
ALNY
#647
Rank
S$50.65 B
Marketcap
S$379.41
Share price
0.57%
Change (1 day)
1.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company